Latest filing published 11 Sept 2023 for Immix Biopharma, Inc., €46k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -33.1%Entry US$2.78 · Close at T+365 US$1.86
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Melissa Jane Buchan: trading record in brief
Filings by Melissa Jane Buchan span 2 companies, the busiest being Globe Life Inc. and Immix Biopharma, Inc. We count 38 filings; the first trade dates from 11 September 2007 and the latest from 7 September 2023.
Market trades split into 2 purchases (€217k) and 11 sales (€3.3M). The net balance comes to €3.1M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 13 share grants and 8 option exercises. Since January 2023: 1 purchase and 1 sale on the market.
The newest entry dates from 11 September 2023: an open-market purchase of €46k, in Immix Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Melissa Jane Buchan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$2.4613100.0% of flowCommon StockSEC:0001493152-23-032280:0Canonical exit: 6 Dec 2023 (T+90)
- 235 shares0Common StockSEC:0001062993-23-014213:0
- 1,900 shares@ US$105.9522.6% of flowCommon StockSEC:0001062993-23-007089:0
- 1,422 shares0Common StockSEC:0001062993-23-000748:0
- 430 shares0Common StockSEC:0001062993-22-022943:0
- 265 shares0Common StockSEC:0001062993-22-015548:0
- 1,791 shares0Common StockSEC:0001062993-22-000520:0
- 570 shares0Common StockSEC:0001062993-21-013301:0
- 1,700 shares@ US$92.077816.0% of flowCommon StockSEC:0001062993-21-010220:0
- 11,667 shares@ US$105.8943.0% of flowCommon StockSEC:0001665773-21-000169:1
- 11,667 shares@ US$54.1661.4% of flowCommon StockSEC:0001665773-21-000169:0
- 1,732 shares0Common StockSEC:0001665773-21-000010:0
- 2,606 shares0Common StrockSEC:0001183084-18-000021:0
- 3,180 shares0Common StrockSEC:0001183084-17-000008:0
- 13,500 shares@ US$19.8918.5% of flowCommon StockSEC:0001183084-16-000454:0
- 3,825 shares@ US$71.1218.7% of flowCommon StrockSEC:0001183084-16-000454:1
- 3,729 shares0Common StockSEC:0001183084-16-000272:0
- 3,729 sharesCommon StockSEC:0001183084-16-000232:0
- 13,500 shares@ US$19.95Common StockSEC:0001183084-15-000210:0
- 4,600 shares@ US$58.77Common StockSEC:0001183084-15-000210:1
- 2,454 shares0Common StockSEC:0001183084-15-000057:0
- 13,500 shares@ US$26.44Common StockSEC:0001183084-14-000198:0
- 6,684 shares@ US$53.46Common StockSEC:0001183084-14-000198:1
- 2,454 shares0Common StockSEC:0001183084-14-000021:0
- 9,000 shares@ US$42.97Common StockSEC:0001183084-13-000110:0
25 of 35 declarations
